Award
Delivery Order #SPE2DR26FF587
AmerisourceBergen Awarded Delivery Order for QuilliVant XR Pharmaceutical Supply
Buyer
Defense Logistics Agency
Award Amount
$223.58
Ceiling
$223.58
Awarded
February 26, 2026
Period of Performance
Feb 26, 2026 – Feb 27, 2026
Identifier
SPE2DR26FF587
NAICS
424210
This award represents a delivery order contract under an existing indefinite delivery vehicle (IDV) held by AmerisourceBergen Drug Corp, a leading pharmaceutical distributor known for supplying essential medications to healthcare providers. The contract specifically procures QuilliVant XR 25 MG/5 ML Suspension in a 180ML quantity, underscoring its role in delivering critical pharmaceutical products. The contract enhances the agency's ability to ensure a reliable and timely supply of vital medications, contributing significantly to public health support and medical service continuity. The scope of work includes the delivery of the specified pharmaceutical product to the designated location in Conshohocken, Pennsylvania, within a concise timeframe of two days. This order is part of a competitive procurement aligned with the broader IDV contract, reflecting an efficient supply chain process. Awarded for a short, defined period, this contract fits within a larger decade-spanning supply framework, demonstrating ongoing commitment to sustained pharmaceutical provisioning.
Description
4570970576!QUILLIVANT XR 25 MG/5 ML SUSP 180ML